MICHAEL PALMS: Open Payments
NPI 1336739739 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 32 payments from 7 companies in 2025. Trend: 2023 $322 · 2024 $604 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $722 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Novo Nordisk Inc | 3 | $72 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $54 |
| Corcept Therapeutics | 1 | $33 |
| Verity Pharmaceuticals Inc. | 1 | $27 |
| PFIZER INC. | 1 | $18 |
Products named: AIRSUPRA, BREZTRI, REXULTI, Ozempic, JOURNAVX, Korlym, Tlando, FARXIGA.
Industry payments across CA — which companies pay providers there.
